FerGene. STAY far far away. Dumpster Fire

[anonymous]

FerGene seems to have a therapy with impressive data and confidence of one of the most savvy biotech investor groups. Unique opportunity to get in on the ground floor or a small biotech company. When are they going to hire sales team?

This aged well.

 

[anonymous]

FerGene seems to have a therapy with impressive data and confidence of one of the most savvy biotech investor groups. Unique opportunity to get in on the ground floor or a small biotech company. When are they going to hire sales team?

This aged well.

 

[anonymous]

This is another start up owned by Ferris and they are a mess!

they will be absorbed in one year or it will fail. The bladder cancer market has spoken and they are not very impressed.

stay far away

Man, this was prophetic.

 

[anonymous]

• Mirati is keeping the news flowing. It’s hired David Meek — the battle-tested CEO, most recently at the center of FerGene’smeltdown — to steer the ship as the biotech preps for an FDA filing of its KRAS-G12C inhibitor, adagrasib, in Q4. On the heels of a data reveal at ESMO, execs touted another topline win for the drug in non-small cell lung cancer, where it posted a 43% response rate in a select group of second-line-or-later patients.
  

 

[anonymous]

Man, this was prophetic.

Accurate. I met with this firm through the poor representation of the bowdoin group. I was so unimpressed and as well it was for managed markets. The entire process was like being pitched a “time share” package in lala land